Literature DB >> 18754879

Enhancement of antiproliferative activity of interferons by RNA interference-mediated silencing of SOCS gene expression in tumor cells.

Yuki Takahashi1, Haruka Kaneda, Nana Takasuka, Kayoko Hattori, Makiya Nishikawa, Yoshihiko Watanabe, Yoshinobu Takakura.   

Abstract

The suppressor of cytokine signaling (SOCS) proteins, negative regulators of interferon (IFN)-induced signaling pathways, is involved in IFN resistance of tumor cells. To improve the growth inhibitory effect of IFN-beta and IFN-gamma on a murine melanoma cell line, B16-BL6, and a murine colon carcinoma cell line, Colon26 cells, SOCS-1 and SOCS-3 gene expression in tumor cells was downregulated by transfection of plasmid DNA expressing short hairpin RNA targeting one of these genes (pshSOCS-1 and pshSOCS-3, respectively). Transfection of pshSOCS-1 significantly increased the antiproliferative effect of IFN-gamma on B16-BL6 cells. However, any other combinations of plasmids and IFN had little effect on the growth of B16-BL6 cells. In addition, transfection of pshSOCS-1 and pshSOCS-3 produced little improvement in the effect of IFN on Colon26 cells. To understand the mechanism underlining these findings, the level of SOCS gene expression was measured by real time polymerase chain reaction. Addition of IFN-gamma greatly increased the SOCS-1 mRNA expression in B16-BL6 cells. Taking into account the synergistic effect of pshSOCS-1 and IFN-gamma on the growth of B16-BL6 cells, these findings suggest that IFN-gamma-induced high SOCS-1 gene expression in B16-BL6 cells significantly interferes with the antiproliferative effect of IFN-gamma. These results indicate that silencing SOCS gene expression can be an effective strategy to enhance the antitumor effect of IFN under conditions in which the SOCS gene expression is upregulated by IFN.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18754879     DOI: 10.1111/j.1349-7006.2008.00850.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  9 in total

1.  The kinase inhibitory region of SOCS-1 is sufficient to inhibit T-helper 17 and other immune functions in experimental allergic encephalomyelitis.

Authors:  Lindsey D Jager; Rea Dabelic; Lilian W Waiboci; Kenneth Lau; Mohammad S Haider; Chulbul M I Ahmed; Joseph Larkin; Samuel David; Howard M Johnson
Journal:  J Neuroimmunol       Date:  2010-12-04       Impact factor: 3.478

2.  Lymph node metastasis is mediated by suppressor of cytokine signaling-3 in gastric cancer.

Authors:  Jingyu Deng; Xuguang Jiao; Honggen Liu; Liangliang Wu; Rupeng Zhang; Baogui Wang; Yi Pan; Xishan Hao; Han Liang
Journal:  Tumour Biol       Date:  2013-07-04

3.  Role of SOCS-1 Gene on Melanoma Cell Growth and Tumor Development.

Authors:  Jorge A Borin Scutti; Alisson Leonardo Matsuo; Felipe Valença Pereira; Mariana Hiromi Massaoka; Carlos Rogério Figueiredo; Dayson Friaça Moreira; José Ernesto Belizário; Luiz R Travassos
Journal:  Transl Oncol       Date:  2011-04-01       Impact factor: 4.243

4.  Modulation of SOCS protein expression influences the interferon responsiveness of human melanoma cells.

Authors:  Gregory B Lesinski; Jason M Zimmerer; Melanie Kreiner; John Trefry; Matthew A Bill; Gregory S Young; Brian Becknell; William E Carson
Journal:  BMC Cancer       Date:  2010-04-14       Impact factor: 4.430

Review 5.  Interleukin-6 induces drug resistance in renal cell carcinoma.

Authors:  Kei Ishibashi; Tomoyuki Koguchi; Kanako Matsuoka; Akifumi Onagi; Ryo Tanji; Ruriko Takinami-Honda; Seiji Hoshi; Mitsutaka Onoda; Yoshimasa Kurimura; Junya Hata; Yuichi Sato; Masao Kataoka; Soichiro Ogawsa; Nobuhiro Haga; Yoshiyuki Kojima
Journal:  Fukushima J Med Sci       Date:  2018-10-23

6.  Tumour-promoting role of SOCS1 in colorectal cancer cells.

Authors:  William S Tobelaim; Claudia Beaurivage; Audrey Champagne; Véronique Pomerleau; Aline Simoneau; Walid Chababi; Mehdi Yeganeh; Philippe Thibault; Roscoe Klinck; Julie C Carrier; Gerardo Ferbeyre; Subburaj Ilangumaran; Caroline Saucier
Journal:  Sci Rep       Date:  2015-09-22       Impact factor: 4.379

7.  Correlation between the suppressor of cytokine signaling-1 and 3 and hepatitis B virus: possible roles in the resistance to interferon treatment.

Authors:  Ling-yao Du; Yao-li Cui; En-qiang Chen; Xing Cheng; Li Liu; Hong Tang
Journal:  Virol J       Date:  2014-03-17       Impact factor: 4.099

8.  Long-term pegylated interferon-alpha and its potential in the treatment of melanoma.

Authors:  Reinhard Dummer; Joanna Mangana
Journal:  Biologics       Date:  2009-07-13

9.  Genomic evidence of adaptive evolution in the reptilian SOCS gene family.

Authors:  Tian Xia; Lei Zhang; Guolei Sun; Xiufeng Yang; Honghai Zhang
Journal:  PeerJ       Date:  2021-06-24       Impact factor: 2.984

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.